Linked Life Data

7152435

Source:http://linkedlifedata.com/resource/pubmed/id/7152435

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
43
pubmed:dateCreated
1983-3-11
pubmed:abstractText
During the last years as a result of improved diagnostic methods and new developed drugs with different mechanism of action the therapy of congestive heart failure has become more differentiated. Digitalis and diuretics constitute conventional therapy, but systemic vasodilators offer an innovative approach in acute and chronic heart failure. The vasodilators produce disparate modifications of cardiac function depending upon their differing alterations of preload and afterload. Nitrates principally cause vasodilation, nitroprusside, phentolamine and prazosin produce balanced arterial and venous dilation, whereas hydralazine predominantly causes arteriolar dilation. New positive inotropic agents like dopamine and dobutamine are still restricted to parenteral use.
pubmed:language
ger
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0015-8178
pubmed:author
pubmed:issnType
Print
pubmed:day
18
pubmed:volume
100
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1993-6
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed:year
1982
pubmed:articleTitle
[Differential therapy of heart insufficiency].
pubmed:publicationType
Journal Article, English Abstract